Phase 1 Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must be between 40 and 75 years old.
- You must be in reasonably good general health and able to carry out most daily activities (confirm with trial site regarding the specific fitness score used).
- You must be able to understand and sign a consent form on your own, without help from others.
- You must have been newly diagnosed with a brain tumor called glioblastoma, identified by brain scans before surgery and confirmed during surgery by examining tumor tissue.
- Your tumor must be in a location where surgeons can remove all or nearly all of it.
- The space left after surgery must be large enough to fit a special radiation balloon device used in this trial.
- If you are a woman who could become pregnant, you must have a negative pregnancy test within 7 days before treatment starts.
- Your blood test results within 7 days before joining must show your bone marrow is working well enough — including healthy levels of infection-fighting cells, platelets, and red blood cells (confirm with trial site for exact numbers).
- Your kidney and liver function tests within 7–14 days before joining must show these organs are working within acceptable limits (confirm with trial site for exact numbers).
- Your urine must show low or no protein levels within 14 days before joining (confirm with trial site for details).
- If you are taking blood-thinning medications, you must have no active bleeding, and your medication dose must have been stable for at least 14 days before joining.
Who may not be able to join:
- Your glioblastoma has spread to multiple separate areas of the brain.
- Your tumor is located in the lower part of the brain (below the main brain) or has spread to the lining of the brain or spinal cord.
- Your glioblastoma has come back or grown again after previous treatment.
- You have had radiation treatment to the brain before.
- Your tumor is located very close to (within about half an inch of) critical brain structures, making it unsafe to deliver the planned radiation.
- The main tumor area that shows up on contrast scans is larger than 6 cm across (roughly the size of a large plum).
- You have or have had another cancer, except for certain treated skin cancers or very early-stage cancers that were fully treated.
- You have or have had any other tumor in the brain.
- You are pregnant, breastfeeding, or unwilling to use reliable contraception during the trial (applies to women who could become pregnant and sexually active men).
- You have a condition that makes MRI scans unsafe for you, such as certain metal implants.
- You have a pacemaker or heart device that cannot be removed and would interfere with the trial.
- You have a condition that makes it unsafe to have general anaesthesia.
- You are currently taking part in another clinical trial.
- You have had serious heart problems (such as a heart attack, chest pain requiring hospital care, or heart failure) within the past 6 months.
- You have had a stroke or mini-stroke within the past 6 months.
- You have serious blood vessel disease, active blood clots, or a severe ongoing infection requiring hospital-level antibiotic treatment.
- You have serious lung, liver, or other major organ problems that could interfere with the trial treatment.
- You have tested positive for HIV, hepatitis B, hepatitis C, or syphilis.
- You have had a significant bleeding episode (rated as serious by medical standards) within 30 days before joining.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Aleksey Krivoshapkin, Professor M.D., Joint-Stock Company European Medical Center
Phone: +7 (925) 288 - 59-29
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Primary Endpoint - Overall Survival (OS) of patients
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.